PROTONIX PANTOPRAZOLE 40MG 14TABS

Description

Healing and prevention of esophageal-gastro-duodenal peptic acid lesions and for the relief of gastrointestinal symptoms associated with acid-peptic disease in those cases in which a sustained control and reduction of gastric hydrochloric acid secretion is required.

Peptic acid disease manifested as: duodenal ulcer, gastric ulcer, * peptic ulcer associated with Helicobacter pylori infection (* patients with acid peptic lesions associated with Helicobacter pylori infection require additional treatment combined with specific antibiotics for its eradication ), refractory peptic ulcer Helicobacter pylori (-) and other lesions refractory to previous treatment with H2 antagonists. Control of Zollinger-Ellison Syndrome, gastroesophageal reflux disease with reflux esophagitis (Savary-Miller GERD grades I, II, III and IV), mild to moderate esophagitis (Vandenplas grades Ic / II) in children 6 to 12 years; Gastroesophageal reflux esophagitis with manifestations and / or extra esophageal lesions associated with reflux (ie dysphonia, asthma, laryngitis, chronic sinusitis, etc.), mild esophagitis with associated symptoms (eg heartburn, acid regurgitation, odynophagia, etc.), long-term maintenance therapy for the prevention of relapses of gastroesophageal reflux, non-erosive gastroesophageal reflux disease (NERD), treatment of heartburn, dyspepsia and other functional digestive disorders associated with acute and chronic acid peptic disease, gastritis and / or duodenitis , erosive gastritis, treatment and prevention of drug gastritis secondary to chronic consumption of non-steroidal anti-inflammatory drugs (NSAIDs). Preoperative prevention of acid aspiration pneumonia (Mendelson syndrome). As a therapeutic diagnostic test to rule out the origin of non-cardiovascular chest pain.